blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2948441

EP2948441 - METHOD FOR PREPARING 1-(4-(4-(3,4-DICHLORO-2-FLUOROPHENYLAMINO)-7-METHOXYQUINAZOLIN-6-YLOXY)PIPERIDIN-1-YL)PROP-2-EN-1-ONE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.11.2018
Database last updated on 13.09.2024
FormerThe patent has been granted
Status updated on  24.11.2017
FormerGrant of patent is intended
Status updated on  20.11.2017
FormerRequest for examination was made
Status updated on  23.10.2017
FormerGrant of patent is intended
Status updated on  24.07.2017
FormerRequest for examination was made
Status updated on  05.07.2017
FormerGrant of patent is intended
Status updated on  06.04.2017
FormerRequest for examination was made
Status updated on  28.03.2017
FormerGrant of patent is intended
Status updated on  27.03.2017
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
Hanmi Pharm. Co., Ltd.
214 Muha-ro
Paltan-myeon
Hwaseong-si
Gyeonggi-do 445-910 / KR
[2015/49]
Inventor(s)01 / BANG, Keuk Chan
4304-501
2 Gwanggyomaeul-ro
Suji-gu
Yongin-si Gyeonggi-do 448-130 / KR
02 / JUNG, Jae Hyuk
302-ho
65 Guksabong 10-gil
Dongjak-gu
Seoul 156-846 / KR
03 / MOON, Young Ho
146-1203
498 Yeongtong-ro
Yeongtong-gu
Suwon-si Gyeonggi-do 443-740 / KR
 [2015/49]
Representative(s)Hocking, Adrian Niall, et al
Albright IP Limited
County House
Bayshill Road
Cheltenham, Glos. GL50 3BA / GB
[2017/52]
Former [2015/49]Hocking, Adrian Niall, et al
Albright IP Limited
Eagle Tower
Montpellier Drive
Cheltenham GL50 1TA / GB
Application number, filing date14743689.327.01.2014
[2015/49]
WO2014KR00752
Priority number, dateKR2013000928228.01.2013         Original published format: KR 20130009282
[2015/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014116070
Date:31.07.2014
Language:EN
[2014/31]
Type: A1 Application with search report 
No.:EP2948441
Date:02.12.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 31.07.2014 takes the place of the publication of the European patent application.
[2015/49]
Type: B1 Patent specification 
No.:EP2948441
Date:27.12.2017
Language:EN
[2017/52]
Search report(s)International search report - published on:KR31.07.2014
(Supplementary) European search report - dispatched on:EP07.06.2016
ClassificationIPC:C07D401/12, A61K31/517, A61P35/00
[2015/49]
CPC:
C07D401/12 (EP,CN,IL,KR,RU,US); A61K31/517 (KR); A61P35/00 (EP,RU);
C07D211/46 (EP,IL,US); C07D239/86 (EP,IL,US); C07D239/94 (EP,IL,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/49]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON 1-(4-(4-(3,4-DICHLOR-2-FLUORPHENYLAMINO) -7-METHOXYCHINAZOLIN-6-YLOXY)PIPERIDIN-1-YL)PROP-2-EN-1-ON[2017/17]
English:METHOD FOR PREPARING 1-(4-(4-(3,4-DICHLORO-2-FLUOROPHENYLAMINO)-7-METHOXYQUINAZOLIN-6-YLOXY)PIPERIDIN-1-YL)PROP-2-EN-1-ONE[2015/49]
French:PROCÉDÉ DE PRÉPARATION DE 1-(4-(4-(3,4-DICHLORO-2-FLUOROPHÉNYLAMINO)- 7-MÉTHOXYQUINAZOLIN-6-YLOXY)PIPÉRIDIN-1-YL)PROP-2-ÉN-1-ONE[2015/49]
Former [2015/49]VERFAHREN ZUR HERSTELLUNG VON 1- (4- (4- (3,4-DICHLOR-2-FLUORPHENYLAMINO) -7-METHOXYCHINAZOLIN-6-YLOXY) PIPERIDIN-1-YL) PROP-2-EN-1-ON
Entry into regional phase16.07.2015National basic fee paid 
16.07.2015Search fee paid 
16.07.2015Designation fee(s) paid 
16.07.2015Examination fee paid 
Examination procedure16.07.2015Examination requested  [2015/49]
30.12.2016Amendment by applicant (claims and/or description)
07.04.2017Communication of intention to grant the patent
26.06.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
25.07.2017Communication of intention to grant the patent
18.10.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
18.10.2017Fee for grant paid
18.10.2017Fee for publishing/printing paid
20.11.2017Information about intention to grant a patent
20.11.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.04.2017
Opposition(s)28.09.2018No opposition filed within time limit [2018/49]
Fees paidRenewal fee
27.01.2016Renewal fee patent year 03
27.01.2017Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.01.2014
AL27.12.2017
CY27.12.2017
CZ27.12.2017
EE27.12.2017
FI27.12.2017
HR27.12.2017
LT27.12.2017
LV27.12.2017
MC27.12.2017
MK27.12.2017
PL27.12.2017
PT27.12.2017
RO27.12.2017
RS27.12.2017
SI27.12.2017
SK27.12.2017
SM27.12.2017
LU27.01.2018
MT27.01.2018
BE31.01.2018
BG27.03.2018
GR28.03.2018
IS27.04.2018
[2020/34]
Former [2020/31]HU27.01.2014
CY27.12.2017
CZ27.12.2017
EE27.12.2017
FI27.12.2017
HR27.12.2017
LT27.12.2017
LV27.12.2017
MC27.12.2017
MK27.12.2017
PL27.12.2017
PT27.12.2017
RO27.12.2017
RS27.12.2017
SI27.12.2017
SK27.12.2017
SM27.12.2017
LU27.01.2018
MT27.01.2018
BE31.01.2018
BG27.03.2018
GR28.03.2018
IS27.04.2018
Former [2020/30]HU27.01.2014
CY27.12.2017
CZ27.12.2017
EE27.12.2017
FI27.12.2017
HR27.12.2017
LT27.12.2017
LV27.12.2017
MC27.12.2017
PL27.12.2017
PT27.12.2017
RO27.12.2017
RS27.12.2017
SI27.12.2017
SK27.12.2017
SM27.12.2017
LU27.01.2018
MT27.01.2018
BE31.01.2018
BG27.03.2018
GR28.03.2018
IS27.04.2018
Former [2020/28]CY27.12.2017
CZ27.12.2017
EE27.12.2017
FI27.12.2017
HR27.12.2017
LT27.12.2017
LV27.12.2017
MC27.12.2017
PL27.12.2017
PT27.12.2017
RO27.12.2017
RS27.12.2017
SI27.12.2017
SK27.12.2017
SM27.12.2017
LU27.01.2018
MT27.01.2018
BE31.01.2018
BG27.03.2018
GR28.03.2018
IS27.04.2018
Former [2020/08]CY27.12.2017
CZ27.12.2017
EE27.12.2017
FI27.12.2017
HR27.12.2017
LT27.12.2017
LV27.12.2017
MC27.12.2017
PL27.12.2017
RO27.12.2017
RS27.12.2017
SI27.12.2017
SK27.12.2017
SM27.12.2017
LU27.01.2018
MT27.01.2018
BE31.01.2018
BG27.03.2018
GR28.03.2018
IS27.04.2018
Former [2019/13]CY27.12.2017
CZ27.12.2017
EE27.12.2017
FI27.12.2017
HR27.12.2017
LT27.12.2017
LV27.12.2017
MC27.12.2017
PL27.12.2017
RO27.12.2017
RS27.12.2017
SI27.12.2017
SK27.12.2017
SM27.12.2017
LU27.01.2018
BE31.01.2018
BG27.03.2018
GR28.03.2018
IS27.04.2018
Former [2018/50]CY27.12.2017
CZ27.12.2017
EE27.12.2017
FI27.12.2017
HR27.12.2017
LT27.12.2017
LV27.12.2017
MC27.12.2017
PL27.12.2017
RO27.12.2017
RS27.12.2017
SK27.12.2017
SM27.12.2017
LU27.01.2018
BE31.01.2018
BG27.03.2018
GR28.03.2018
IS27.04.2018
Former [2018/47]CY27.12.2017
CZ27.12.2017
EE27.12.2017
FI27.12.2017
HR27.12.2017
LT27.12.2017
LV27.12.2017
MC27.12.2017
PL27.12.2017
RO27.12.2017
RS27.12.2017
SK27.12.2017
SM27.12.2017
LU27.01.2018
BG27.03.2018
GR28.03.2018
IS27.04.2018
Former [2018/44]CY27.12.2017
CZ27.12.2017
EE27.12.2017
FI27.12.2017
HR27.12.2017
LT27.12.2017
LV27.12.2017
MC27.12.2017
PL27.12.2017
RO27.12.2017
RS27.12.2017
SK27.12.2017
SM27.12.2017
BG27.03.2018
GR28.03.2018
IS27.04.2018
Former [2018/40]CY27.12.2017
CZ27.12.2017
EE27.12.2017
FI27.12.2017
HR27.12.2017
LT27.12.2017
LV27.12.2017
PL27.12.2017
RO27.12.2017
RS27.12.2017
SK27.12.2017
SM27.12.2017
BG27.03.2018
GR28.03.2018
IS27.04.2018
Former [2018/38]CY27.12.2017
CZ27.12.2017
EE27.12.2017
FI27.12.2017
HR27.12.2017
LT27.12.2017
LV27.12.2017
PL27.12.2017
RS27.12.2017
SK27.12.2017
SM27.12.2017
BG27.03.2018
GR28.03.2018
IS27.04.2018
Former [2018/37]CY27.12.2017
CZ27.12.2017
EE27.12.2017
FI27.12.2017
HR27.12.2017
LT27.12.2017
LV27.12.2017
PL27.12.2017
RS27.12.2017
SK27.12.2017
SM27.12.2017
BG27.03.2018
GR28.03.2018
Former [2018/25]FI27.12.2017
HR27.12.2017
LT27.12.2017
LV27.12.2017
RS27.12.2017
BG27.03.2018
GR28.03.2018
Former [2018/23]FI27.12.2017
HR27.12.2017
LT27.12.2017
RS27.12.2017
GR28.03.2018
Former [2018/22]FI27.12.2017
LT27.12.2017
Documents cited:Search[A]WO2005033096  (BOEHRINGER INGELHEIM INT [DE], et al);
 [A]WO2007118854  (EURO CELTIQUE SA [LU], et al);
 [ID]WO2008150118  (HANMI PHARM IND CO LTD [KR], et al);
 [AP]WO2013051883  (HANMI SCIENCE CO LTD [KR]);
International search[A]WO2008150118  (HANMI PHARM IND CO LTD [KR], et al);
 [A]WO2011155793  (HANMI HOLDINGS CO LTD [KR], et al);
 [A]WO2012169733  (HANMI PHARM IND CO LTD [KR], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.